Skip to main content

Table 3 Main * diagnoses of the 1449 events reported in HIV-infected adults receiving antiretroviral treatment, IeDEA West Africa, December 2009 to December 2011

From: Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration

Diagnosis classification, number (%)

Total 1449

Aconda-CePReF

CMSDS

CTA/CNHU

N = 1449

n = 955

n = 239

n = 255

AIDS-defining events

        

   WHO stage 4 events

137

(9.5)

68

(7.1)

31

(13)

38

(14.9)

   WHO stage 3 events

338

(23.3)

214

(22.4)

24

(10)

100

(39.2)

   WHO stage 2 events

6

(0.4)

5

(0.5)

0

(0)

1

(0,4)

Non-AIDS-defining events

        

   Non AIDS classifying infections

472

(32.6)

379

(39.7)

51

(21.3)

42

(16.5)

   Side effects**

104

(7.2)

34

(3.6)

32

(13.4)

38

(14.9)

   Other diagnosed diseases

63

(4.3)

35

(3.7)

12

(5)

16

(6.3)

Syndromic diagnoses***

228

(16.0)

160

(17.0)

55

(23.0)

13

(5.1))

Death

101

(7.0)

60

(6.0)

34

(14.2)

7

(3.0)

  1. *: one diagnosis per event.
  2. **: (anemia = 36, peripheral neuropathy = 33, toxiderma = 21, neutropenia = 5, lipodystrophy = 4, acute delusional psychosis = 2, hyperlactatemia = 2, hepatitis = 1).
  3. ***[anemia = 72, fever = 46, general signs (Asthenia, anorexia = 37), digestive signs (diarrhea, vomiting) = 30, other signs = 43].